Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-26-057121
Filing Date
2026-08-14
Accepted
2026-08-14 16:13:53
Documents
47
Period of Report
2026-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bfrg-20260630.htm   iXBRL 10-Q 659299
2 EX-31.1 bfrg-20260630xex311.htm EX-31.1 11387
3 EX-31.2 bfrg-20260630xex312.htm EX-31.2 11231
4 EX-32.1 bfrg-20260630xex321.htm EX-32.1 4650
5 EX-32.2 bfrg-20260630xex322.htm EX-32.2 4733
  Complete submission text file 0001628280-26-057121.txt   4512298

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bfrg-20260630.xsd EX-101.SCH 35957
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bfrg-20260630_cal.xml EX-101.CAL 30813
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bfrg-20260630_def.xml EX-101.DEF 208008
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bfrg-20260630_lab.xml EX-101.LAB 531321
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bfrg-20260630_pre.xml EX-101.PRE 342584
51 EXTRACTED XBRL INSTANCE DOCUMENT bfrg-20260630_htm.xml XML 391504
Mailing Address 325 ELLINGTON BLVD. UNIT 317 GAITHERSBURG MD 20878
Business Address 325 ELLINGTON BLVD. UNIT 317 GAITHERSBURG MD 20878 3013672055
BullFrog AI Holdings, Inc. (Filer) CIK: 0001829247 (see all company filings)

EIN.: 844786155 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41600 | Film No.: 261281751
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)